Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Obesity-Associated Alterations of Natural Killer Cells and Immunosurveillance of Cancer
Ina Bähr, Julia Spielmann, Dagmar Quandt, et al.
Frontiers in Immunology (2020) Vol. 11
Open Access | Times Cited: 82

Showing 1-25 of 82 citing articles:

COVID-19 and Obesity: Dangerous Liaisons
Grazia Caci, Adriana Albini, Mario Malerba, et al.
Journal of Clinical Medicine (2020) Vol. 9, Iss. 8, pp. 2511-2511
Open Access | Times Cited: 174
The interplay between obesity, immunosenescence, and insulin resistance
Ghazaleh Shimi, Mohammad Hassan Sohouli, Arman Ghorbani, et al.
Immunity & Ageing (2024) Vol. 21, Iss. 1
Open Access | Times Cited: 20
The obesity-autophagy-cancer axis: Mechanistic insights and therapeutic perspectives
Amir Barzegar Behrooz, Marco Cordani, Alessandra Fiore, et al.
Seminars in Cancer Biology (2024) Vol. 99, pp. 24-44
Open Access | Times Cited: 13
Challenges at the Time of COVID-19: Opportunities and Innovations in Antivirals from Nature
Andreas Hensel, Rudolf Bauer, Michael Heinrich, et al.
Planta Medica (2020) Vol. 86, Iss. 10, pp. 659-664
Open Access | Times Cited: 95
Interleukin-6 in SARS-CoV-2 induced disease: Interactions and therapeutic applications
Jamal Majidpoor, Keywan Mortezaee
Biomedicine & Pharmacotherapy (2021) Vol. 145, pp. 112419-112419
Open Access | Times Cited: 55
Obesity and Higher Risk for Severe Complications of Covid-19: What to do when the two pandemics meet
Alessandra Valerio, Enzo Nisoli, Andrea P. Rossi, et al.
Journal of Population Therapeutics and Clinical Pharmacology (2020) Vol. 27, Iss. SP1, pp. e31-e36
Open Access | Times Cited: 61
Leptin, Both Bad and Good Actor in Cancer
Carlos Jiménez‐Cortegana, Ana López-Saavedra, Flora Sánchez-Jiménez, et al.
Biomolecules (2021) Vol. 11, Iss. 6, pp. 913-913
Open Access | Times Cited: 47
Obesity and COVID-19: Mechanistic Insights From Adipose Tissue
Lili Yu, Xiaoying Zhang, Sarah Ye, et al.
The Journal of Clinical Endocrinology & Metabolism (2022) Vol. 107, Iss. 7, pp. 1799-1811
Open Access | Times Cited: 27
Metabolic regulation of NK cell function: implications for immunotherapy
Hyogon Sohn, Megan A. Cooper
Immunometabolism (2023) Vol. 5, Iss. 1, pp. e00020-e00020
Open Access | Times Cited: 20
Learning from the nexus of autoimmunity and cancer
Davide Mangani, Dandan Yang, Ana C. Anderson
Immunity (2023) Vol. 56, Iss. 2, pp. 256-271
Open Access | Times Cited: 17
Leptin, NK cells, and the weight of immunity: Insights into obesity
Arthur Gomes de Andrade, Shayenne Eduarda Ramos Vanderley, Luana Costa de Souza Marques, et al.
International Immunopharmacology (2025) Vol. 147, pp. 113992-113992
Closed Access
Impact of Sarcopenia, BMI, and Inflammatory Biomarkers on Survival in Advanced Hepatocellular Carcinoma Treated With Anti-PD-1 Antibody
Mehmet Akce, Yuan Liu, Katerina Zakka, et al.
American Journal of Clinical Oncology (2020) Vol. 44, Iss. 2, pp. 74-81
Closed Access | Times Cited: 46
Natural Killer Cells: Friend or Foe in Metabolic Diseases?
Yi Li, Fangjie Wang, Saber İmani, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 32
The Weight of Obesity in Immunity from Influenza to COVID-19
Fernanda Brandi Andrade, Ana Cristina Moura Gualberto, CAMILA PEREIRA DE REZENDE, et al.
Frontiers in Cellular and Infection Microbiology (2021) Vol. 11
Open Access | Times Cited: 32
When a Friend Becomes Your Enemy: Natural Killer Cells in Atherosclerosis and Atherosclerosis-Associated Risk Factors
Maria Teresa Palano, Martina Cucchiara, Matteo Gallazzi, et al.
Frontiers in Immunology (2022) Vol. 12
Open Access | Times Cited: 24
Hypothesis: mPGES-1-Derived Prostaglandin E2, a So Far Missing Link in COVID-19 Pathophysiology?
Jan Smeitink, Xiaolan Jiang, S. A. Pecheritsyna, et al.
(2020)
Open Access | Times Cited: 35
Obesity and immune status in children
Xingyuan Fang, Jorge Henao-Mejía, Sarah E. Henrickson
Current Opinion in Pediatrics (2020) Vol. 32, Iss. 6, pp. 805-815
Open Access | Times Cited: 32
Natural killer cell therapy: A new frontier for obesity-associated cancer
Eimear Mylod, Joanne Lysaght, Melissa J. Conroy
Cancer Letters (2022) Vol. 535, pp. 215620-215620
Open Access | Times Cited: 21
Biomarker signature and pathophysiological pathways in patients with chronic heart failure and metabolic syndrome
Camilla C.S. van der Hoef, Eva M. Boorsma, Johanna E. Emmens, et al.
European Journal of Heart Failure (2023) Vol. 25, Iss. 2, pp. 163-173
Open Access | Times Cited: 10
A Comprehensive Review of Hepatitis B Vaccine Nonresponse and Associated Risk Factors
Albashir Tahir, Saadatu Haruna Shinkafi, Ahmed Subeh Alshrari, et al.
Vaccines (2024) Vol. 12, Iss. 7, pp. 710-710
Open Access | Times Cited: 3
Metformin as a therapeutic agent for obesity-associated immune dysfunction
Devika Rajeev, Nancie J. MacIver
Journal of Nutrition (2024) Vol. 154, Iss. 8, pp. 2534-2542
Closed Access | Times Cited: 3
Obesity, Nutrients and the Immune System in the Era of COVID-19
Jean‐Pascal De Bandt, Charlotte Monin
Nutrients (2021) Vol. 13, Iss. 2, pp. 610-610
Open Access | Times Cited: 25
In quest of a new therapeutic approach in COVID-19: the endocannabinoid system
Ondine Lucaciu, Ovidiu Aghiorghiesei, Nausica Bianca Petrescu, et al.
Drug Metabolism Reviews (2021) Vol. 53, Iss. 4, pp. 478-490
Open Access | Times Cited: 24
The effects of acute exercise and inflammation on immune function in early-stage prostate cancer
Tim Schauer, Sissal Sigmundsdóttir Djurhuus, Casper Simonsen, et al.
Brain Behavior & Immunity - Health (2022) Vol. 25, pp. 100508-100508
Open Access | Times Cited: 17
NK and cells with NK-like activities in cancer immunotherapy-clinical perspectives
Keywan Mortezaee, Jamal Majidpoor
Medical Oncology (2022) Vol. 39, Iss. 9
Closed Access | Times Cited: 16
Page 1 - Next Page

Scroll to top